TickerFactsScreenerDevelopers

Vistagen Therapeutics, Inc. (VTGN) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$841.3K2012: -$3.57M2013: -$3.46M2014: -$2.13M2015: -$2.77M2018: -$9.06M2019: -$14.53M2020: -$15.76M2021: -$12.07M2022: -$45.26M2023: -$49.72M2024: -$25.81M2025: -$42.10M2026: -$66.44M-$66.44M
2011Operating Cash Flow (USD)2026
Fiscal YearOperating Cash FlowChange YoY
2026-$66.44M-57.8%
2025-$42.10M-63.1%
2024-$25.81M+48.1%
2023-$49.72M-9.9%
2022-$45.26M-274.8%
2021-$12.07M+23.4%
2020-$15.76M-8.5%
2019-$14.53M-60.4%
2018-$9.06M—
2015-$2.77M-30.2%
2014-$2.13M+38.6%
2013-$3.46M+2.9%
2012-$3.57M-323.8%
2011-$841.3K—